FDA Proposes Major Revision Of Breastfeeding And Pregnancy Drug Labels

The US Food and Drug Administration (FDA) announced yesterday Wednesday 28th May, that it was putting forward major revisions to the physician labelling of prescription, including biological, drugs to better inform how these products affect mothers and babies during pregnancy and breastfeeding, so that for example, doctors can make better prescribing decisions and be in a better position to give advice to women who are or could fall pregnant.

More: continued here

Filed under: Pregnancy on June 1st, 2008